First Time Loading...

Integra Lifesciences Holdings Corp
NASDAQ:IART

Watchlist Manager
Integra Lifesciences Holdings Corp Logo
Integra Lifesciences Holdings Corp
NASDAQ:IART
Watchlist
Price: 28.75 USD -1.47% Market Closed
Updated: May 3, 2024
IART
/
Income Statement
/
Revenue

Integra Lifesciences Holdings Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Integra Lifesciences Holdings Corp
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Integra Lifesciences Holdings Corp
NASDAQ:IART
Revenue
$1.5B
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
6%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.7B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$21B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

Integra Lifesciences Holdings Corp
Revenue Breakdown

Breakdown by Geography
Integra Lifesciences Holdings Corp

Total Revenue: 1.5B USD
100%
United States (Includes Long-Lived Assets In ...: 1.1B USD
71.4%
Asia Pacific: 193.1m USD
12.5%
Europe: 165.2m USD
10.7%
Rest Of The World: 82.5m USD
5.4%
Show More
Show Less

Breakdown by Segments
Integra Lifesciences Holdings Corp

Total Revenue: 1.5B USD
100%
Codman Specialty Surgical: 1.1B USD
68.7%
Neurosurgery: 818.1m USD
53.1%
Tissue Technologies: 482.6m USD
31.3%
Wound Reconstruction And Care: 374m USD
24.3%
Instruments: 240.9m USD
15.6%
Private Label: 108.6m USD
7%
Show More
Show Less

See Also

What is Integra Lifesciences Holdings Corp's Revenue?
Revenue
1.5B USD

Based on the financial report for Dec 31, 2023, Integra Lifesciences Holdings Corp's Revenue amounts to 1.5B USD.

What is Integra Lifesciences Holdings Corp's Revenue growth rate?
Revenue CAGR 10Y
6%

Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for Integra Lifesciences Holdings Corp have been 4% over the past three years , 1% over the past five years , and 6% over the past ten years .

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.